Multiple interactions of complement factor h with its ligands in solution: A progress report

Advances in Experimental Medicine and Biology

Volumn 703, Issue , 2010, Pages 25-47

  Perkins, Stephen J ^a   Nan, Ruodan ^b   Okemefuna, Azubuike I ^b   Li, Keying ^b   Khan, Sanaullah ^b   Miller, Ami ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3C; COMPLEMENT COMPONENT C3D; COMPLEMENT FACTOR H; HEPARIN; HISTIDINE; ISOLEUCINE; REGULATOR PROTEIN; SHORT COMPLEMENT REGULATOR; TYROSINE; UNCLASSIFIED DRUG; VALINE; ZINC; LIGAND; MULTIPROTEIN COMPLEX;

ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; GENETIC POLYMORPHISM; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RETINA MACULA AGE RELATED DEGENERATION; STRUCTURE ANALYSIS; BIOPHYSICS; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; RETINA MACULA DEGENERATION; REVIEW; SOLUTION AND SOLUBILITY;

BIOPHYSICAL PHENOMENA; C-REACTIVE PROTEIN; COMPLEMENT C3D; COMPLEMENT FACTOR H; HEPARIN; HUMANS; LIGANDS; MACULAR DEGENERATION; MODELS, MOLECULAR; MULTIPROTEIN COMPLEXES; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; SOLUTIONS; ZINC;

EID: 77955965634     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-5635-4_3     Document Type: Article

References (66)

1. AREDS Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 119:1417-1436
2. AREDS Research Group (2002) The effect of five-year zinc supplementation on serum zinc, serum cholesterol and haemocrit in persons randomly assigned to treatment group in the agerelated eye disease study. J Nutr 132:687-702
3. Aslam M, Perkins SJ (2001) Folded-back solution structure of monomeric Factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling. J Mol Biol 309:1117-1138 (Pubitemid 32623312)
4. Bíró A, Rovó Z, Papp D, Cervenak L, Varga L, Füst G, Thielens NM, Arlaud GJ, Prohászka Z (2007) Studies on the interactions between C-reactive protein and complement proteins. Immunology 121:40-50 (Pubitemid 46537662)
5. Black S, Kushner I, Samols D (2004) C-reactive protein. J Biol Chem 279:48487-48490 (Pubitemid 39625721)
6. Blizniukov OP, Kozmin LD, Falikova VV, Martynov AI, Tischenko VM (2003) Effect of calcium ions on hydrodynamic properties of pentameric and decameric C-reactive protein in solution. Mol Biol 37:912-918 (Pubitemid 39011157)
7. Christopeit T, Gossas T, Danielson UH (2009) Characterization of Ca2+ and phosphocholine interactions with C-reactive protein using a surface plasmon resonance biosensor. Anal Biochem 391:39-44
8. Clark SJ, Higman VA, Mulloy B, Perkins SJ, Lea SM, Sim RB, Day AJ (2006) H384 allotypic variant of factor H associated with age-related macular degeneration has different heparinbinding properties from the non-disease associated form. J Biol Chem 281:24713-24720 (Pubitemid 44274245)
9. DiScipio RG (1992) Ultrastructures and interactions of complement factors H and I. J Immunol 149:2592-2599
10. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308:421-424 (Pubitemid 40530082)
11. Fenaille F, Le Mignon M, Groseil C, Ramon C, Riandé S, Siret L, Bihoreau N (2007) Site-specific N-glycan characterization of human complement factor H. Glycobiology 17:932-944 (Pubitemid 47423883)
12. Fernando AN, Furtado PB, Clark SJ, Gilbert HE, Day AJ, Sim RB, Perkins SJ (2007) Associative and structural properties of the region of complement Factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin. J Mol Biol 368:564-581 (Pubitemid 46483491)
13. Gilbert HE, Eaton JT, Hannan JP, Holers VM, Perkins SJ (2005) Solution structure of the complex between CR2 SCR 1-2 and C3d of human complement: an X-ray scattering and sedimentation modelling study. J Mol Biol 346:859-873 (Pubitemid 40247723)
14. Gros P, Milder FJ, Janssen BJ (2008) Complement driven by conformational changes. Nat Rev Immunol 8:48-58
15. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102:7227-7232 (Pubitemid 40696361)
16. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308:419-421 (Pubitemid 40530081)
17. Hakobyan S, Harris CL, Tortajada A, Goicochea de Jorge E, García-Layana A, Fernández- Robredo P, Rodriguez de Córdoba S, Morgan BP (2008a) Measurement of factor H variants in plasma using variant-specific monoclonal antibodies: application to assessing risk of agerelated macular degeneration. Invest Ophthalmol Vis Sci 49:1983-1990
18. Hakobyan S, Harris CL, Van den Berg CW, Fernandez-Alonso MC, Goicoechea de Jorge E, Rodriguez de Cordoba S, Rivas G, Mangione P, Pepys MB, Morgan BP (2008b) Complement factor H binds to denatured rather than to pentameric C-reactive protein. J Biol Chem 283:30451-30460
19. Hannan JP, Young KA, Guthridge JM, Asokan R, Szakonyi G, Chen XS, Holers VM (2005) Mutational analysis of the Complement Receptor Type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d. J Mol Biol 346:845-858 (Pubitemid 40247722)
20. Herbert AP, Deakin JA, Schmidt CQ, Blaum BS, Egan C, Ferreira VP, Pangburn MK, Lyon M, Uhrin D, Barlow PN (2007) Structure shows that a glycosaminoglycan and protein recognition site in Factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism. J Biol Chem 282:18960-18968 (Pubitemid 47100149)
21. Hocking HG, Herbert AP, Kavanagh D, Soares DC, Ferreira VP, Pangburn MK, Uhrín D, Barlow PN (2008) Structure of the N-terminal region of complement factor H and conformational implications of disease-linked sequence variations. J Biol Chem 283:9475-9487
22. Hurwitz S (1996) Homeostatic control of plasma calcium concentration. Crit Rev Biochem Mol Biol 31:41-100 (Pubitemid 26076457)
23. Janeway CA, Travers P, Walport M, Schlomchik MJ (2005) Immunobiology: the immune system in health and disease. Garland Science, New York
24. Janssen BJ, Huizinga EG, Raaijmakers HC, Roos A, Daha MR, Nilsson-Ekdahl K, Nilsson B, Gros P (2005) Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437:505-511 (Pubitemid 41613542)
25. Johnson PT, Betts KE, Radeke MJ, Hageman GS, Anderson DH, Johnson LV (2006) Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci U S A 103:17456-17461 (Pubitemid 44788990)
26. Jokiranta TS, Jaakola VP, Lehtinen MJ, Parepalo M, Meri S, Goldman A (2006) Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome. EMBO J 25:1784-1794
27. Khan S, Gor J, Mulloy B, Perkins SJ (2008) Solution structure of heparin and its complexes with the factor H SCR-6/8 domains and factor H: implications for disease. Mol Immunol 45:4126, abstract
28. Khan S, Gor J, Mulloy B, Perkins SJ (2010) Semi-rigid solution structures of heparin by constrained X-ray scattering modelling: new insight into heparin-protein complexes. J Mol Biol 395:504-521
29. Kinoshita CM, Ying SC, Hugli TE, Potempa LA, Jiang H, Houghten RA, Gewurz H (1989) Elucidation of a protease sensitive site involved in the binding of calcium to C-reactive protein. Biochemistry 28:9840-9848 (Pubitemid 20022333)
30. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, Sangiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385-389 (Pubitemid 40530070)
31. Klein ML, Francis PJ, Rosner B, Reynolds R, Hamon SC, Schultz DW, Ott J, Seddon JM (2008) CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for agerelated macular degeneration. Ophthalmology 115:1019-1025
32. Laine M, Jarva H, Seitsonen S, Haapasalo K, Lehtinen MJ, Lindeman N, Anderson DH, Johnson PT, Järvelä I, Jokiranta TS, Hageman GS, Immonen I, Meri S (2007) Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J Immunol 178:3831-3836 (Pubitemid 46417652)
33. Lengyel I, Peto T (2008) Cure or cause: the opposing roles for zinc in age-related macular degeneration. Expert Rev Ophthalmol 3:1-4 (Pubitemid 351982403)
34. Lengyel I, Flinn JM, Peto T, Linkous DH, Cano K, Bird AC, Lanzirotti A, Frederickson CJ, van Kuijk FJGM (2007) High concentration of zinc in sub-retinal pigment epithelial deposits. Exp Eye Res 84:772-780 (Pubitemid 46400642)
35. Li K, Okemefuna AI, Gor J, Hannan JP, Asokan R, Holers VM, Perkins SJ (2008) Solution structure of the complex formed between human complement C3d and full length complement receptor Type 2. J Mol Biol 384:137-150
36. Nan R, Gor J, Perkins SJ (2008a) Implications of the progressive self-association of wild-type human Factor H for complement regulation and disease. J Mol Biol 375:891-900 (Pubitemid 350309396)
37. Nan R, Gor J, Lengyel I, Perkins SJ (2008b) Uncontrolled zinc and copper-induced oligomerisation of the human complement regulator Factor H and its possible implications for function and disease. J Mol Biol 384:1341-1352
38. Nan R, Ward G, Gor J, Lengyel I, Perkins SJ (2009) Self-association of the Tyr402 and His402 allotypes of complement factor H in the absence and presence of zinc. Abstract. First international conference on inflammation and retinal disease: complement biology and pathology, Heraklion, Crete, Greece, June 26-July 1, 2009
39. Okemefuna AI, Gilbert HE, Griggs KM, Ormsby RJ, Gordon DL, Perkins SJ (2008) The regulatory SCR-1/5 and cell-surface-binding SCR-16/20 fragments of Factor H reveal partially folded-back solution structures and different self-associative properties. J Mol Biol 375:80-101 (Pubitemid 350161888)
40. Okemefuna AI, Nan R, Gor J, Perkins SJ (2009a) Electrostatic interactions contribute to the folded-back conformation of wild-type human Factor H. J Mol Biol 391:98-118
41. Okemefuna AI, Li K, Nan R, Ormsby RJ, Sadlon T, Gordon DL, Perkins SJ (2009b) Multimeric interactions between complement Factor H and its C3d ligand provide new insight on complement regulation. J Mol Biol 391:119-135
42. Okemefuna AI, Stach L, Rana S, Ziai Buetas AJ, Gor J, Perkins SJ (2010a) C-reactive protein exists in an NaCl concentration dependent pentamer-decamer equilibrium in physiological buffer. J Biol Chem 285:1041-1052
43. Okemefuna AI, Nan R, Miller A, Gor J, Perkins SJ (2010b) Complement Factor H binds at two independent sites to C-reactive protein in acute-phase concentrations. J Biol Chem 285:1053-1065
44. Ormsby RJ, Ranganathan S, Tong JC, Griggs KM, Dimasi DP, Hewitt AW, Burdon KP, Craig JE, Hoh J, Gordon DL (2008) Functional and structural implications of the complement factor H Y402H polymorphism associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 49:1763-1770
45. Pangburn MK, Rawal N, Cortes C, Alam MN, Ferreira VP, Atkinson MA (2009) Polyanioninduced self-association of complement factor H. J Immunol 182:1061-1068
46. Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111:1805-1812 (Pubitemid 38057722)
47. Perkins SJ, Furtado PB (2005) Complement and immunoglobulin protein structures by X-ray and neutron solution scattering and analytical ultracentrifugation. In: Morikis D, Lambris JD (eds) Structural biology of the complement system. Taylor and Francis, Boca Raton, pp 293-315
48. Perkins SJ, Pepys MB (1986) X-ray and neutron scattering studies on CRP and SAP. Protides Biol Fluids 34:323-326
49. Perkins SJ, Sim RB (1986) Molecular modelling of human complement component C3 and its fragments by solution scattering. Eur J Biochem 157:155-168
50. Perkins SJ, Nealis AS, Sim RB (1990) Molecular modelling for human complement component C4 and its fragments by X-ray and neutron solution scattering. Biochemistry 29:1167-1175 (Pubitemid 20053838)
51. Perkins SJ, Nealis AS, Sim RB (1991) Oligomeric domain structure of human complement factor H by X-ray and neutron solution scattering. Biochemistry 30:2847-2857
52. Perkins SJ, Okemefuna AI, Nan R (2010) Unravelling protein-protein interactions between complement factor H and C-reactive protein by a multidisciplinary strategy. Biochem Soc Trans In press
53. Prosser BE, Johnson S, Roversi P, Herbert AP, Blaum BS, Tyrrell J, Jowitt TA, Clark SJ, Tarelli E, Uhrin D, Barlow PN, Sim RB, Day AJ, Lea SM (2007) Structural basis for complement factor H - linked age-related macular degeneration. J Exp Med 204:2277-2283 (Pubitemid 47529315)
54. Prota AE, Sage DR, Stehle T, Fingeroth JD (2002) The crystal structure of human CD21: implications for Epstein-Barr virus and C3d binding. Proc Natl Acad Sci U S A 99:10641-10646
55. Saunders RE, Goodship THJ, Zipfel PF, Perkins SJ (2006) Factor H-associated haemolytic uraemic syndrome: a web database of the structural consequences of disease-associated mutations. Hum Mutat 27:21-30 (Pubitemid 43042963)
56. Saunders RE, Abarrategui-Garrido C, Frémeaux-Bacchi V, Goicoechea de Jorge E, Goodship THJ, López Trascasa M, Noris M, Ponce Castro IM, Remuzzi G, Rodríguez de Córdoba S, Sánchez-Corral P, Zipfel PF, Perkins SJ (2007) The interactive factor H - atypical haemolytic uraemic syndrome mutation database and website: update and integration of membrane cofactor protein and factor I mutations with structural models. Hum Mutat 28:222-234
57. Schmidt CQ, Herbert AP, Kavanagh D, Gandy C, Fenton CJ, Blaum BS, Lyon M, Uhrín D, Barlow PN (2008) A new map of glycosaminoglycan and C3b binding sites on factor H. J Immunol 181:2610-2619
58. 1H (factor H). Biochem J 205:285-293 (Pubitemid 13226501)
59. Sjöberg AP, Trouw LA, Clark SJ, Sjölander J, Heinegård D, Sim RB, Day AJ, Blom AM (2007) The factor H variant associated with age-related macular degeneration (His-384) and the nondisease associated form bind differentially to C-reative protein, fibromodulin, DNA and necrotic cells. J Biol Chem 282:10894-10900 (Pubitemid 47100772)
60. Skerka C, Lauer N, Weinberger AA, Keilhauer CN, Sühnel J, Smith R, Schlötzer-Schrehardt U, Fritsche L, Heinen S, Hartmann A, Weber BH, Zipfel PF (2007) Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. Mol Immunol 44:3398-3406 (Pubitemid 46678196)
61. Szakonyi G, Guthridge JM, Li D, Young KA, Holers VM, Chen XS (2001) Structure of complement receptor 2 in complex with its C3d ligand. Science 292:1725-1728 (Pubitemid 32506247)
62. Thompson D, Pepys MB, Wood SP (1999) The physiological structure of human C-reactive protein and its complex with phosphocholine. Struct Fold Des 7:169-177 (Pubitemid 29159702)
63. Ugarte M, Osborne NN (2001) Zinc in the retina. Prog Neurobiol 64:219-249 (Pubitemid 32193781)
64. Walport MJ (2001) Complement. N Engl J Med 344:1058-1066, and 1140-1144
65. Wu J, Wu YQ, Ricklin D, Janssen BJ, Lambris JD, Gros P (2009) Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat Immunol 10:728-733
66. Yu J, Wiita P, Kawaguchi R, Honda J, Jorgensen A, Zhang K, Fischetti VA, Sun H (2007) Biochemical analysis of a common human polymorphism associated with age-related macular degeneration. Biochemistry 46:8451-8461 (Pubitemid 47075982)